Despite these differences in secretory mechanisms, both IL-6 and CCL-2 are consistently elevated in the serum and broncho-alveolar lavage (BAL) fluid of patients with ALI/ARDS and correlate with patient mortality rates [12,13]. The gene discussed is CCL2; the disease is acute respiratory distress syndrome.